专利检索 ap:("Prosidion Limited") AND inv:"FYFE, Matthew Colin Thor, Prosidion Ltd" 第 1 页

1.

发明公开
G-PROTEIN COUPLED RECEPTOR (GPR116) AGONISTS AND USE THEREOF FOR TREATING OBESITY AND DIABETES 审中-公开
标题翻译： G蛋白偶联受体（GPR116）激动剂及其用途肥胖和糖尿病的治疗

公开(公告)号：EP1838311A1

公开(公告)日：2007-10-03

申请号：EP05821803.3

申请日：2005-12-23

申请人： Prosidion Limited

发明人： FYFE, Matthew Colin Thor, Prosidion Ltd , BERTRAM, Lisa, Sarah, Prosidion Ltd , THOMAS, Gerard Hugh, Prosidion Ltd , WILLIAMS, Geoffrey Martyn, Prosidion Ltd

IPC分类号： A61K31/44 , C07D401/12 , A61P3/04 , A61P3/10

CPC分类号： C07D213/83 , C07D213/32 , C07D401/12 , C07D401/14 , C07D405/14

摘要： Compounds of formula (I), or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful for the treatment of obesity, and for the treatment of diabetes.

2.

发明公开
PYRIMIDINE DERIVATIVES AS GPCR AGONISTS 有权
标题翻译：嘧啶衍生物AS GPCR受体激动剂

公开(公告)号：EP1838698A1

公开(公告)日：2007-10-03

申请号：EP05821785.2

申请日：2005-12-30

申请人： Prosidion Limited

发明人： BRADLEY, Stuart Edward, Prosidion Ltd , FYFE, Matthew Colin Thor, Prosidion Ltd , THOMAS, Gerard Hugh, Prosidion Ltd

IPC分类号： C07D401/14 , A61K31/495 , A61P3/00

CPC分类号： C07D401/14

摘要： Compounds of formula (I): R1-A-V-B-R2 , wherein V is phenyl or a 6-membered heteroaryl ring containing up to three N-atoms, or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful for the treatment of obesity, and for the treatment of diabetes.